Примери за използване на Application was submitted на Английски и техните преводи на Български
{-}
-
Official
-
Medicine
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The application was submitted in August 2016.
Org was registered three days after the application was submitted.
The application was submitted in August 2016.
Without prejudice to paragraphs 2 and 3,a retroactive authorisation shall take effect on the date the application was submitted.
The application was submitted under Article 10(3) of Directive 2001/83/EC.
Without prejudice to paragraphs 2 and 3,a retroactive authorisation shall take effect on the date the application was submitted.
The application was submitted to the Concerned Member States under the mutual recognition procedure.
(2) In accordance with Article 7 of Regulation(EC) No 1831/2003, an application was submitted for the authorisation of copper bilysinate.
The application was submitted to the Concerned Member State, Ireland, under the mutual recognition procedure.
In accordance with Article 6(2) and(4) of Regulation(EC) No 396/2005 an application was submitted for quizalofop-P-ethyl used on maize in Canada.
The application was submitted as a generic of the reference product, Synulox Palatable Tablets 50 mg marketed by Pfizer Ltd.
In accordance with Article 6(2)and(4) of Regulation(EC) No 396/2005 an application was submitted for flutriafol used on cucurbits with edible peel.
The application was submitted to Hungary, which had been designated rapporteur Member State by Regulation(EC) No 2229/2004.
In the repeat use of the Mutual Recognition procedure,which started on 11 October 2005, the application was submitted to the Concerned Member States(CMS).
The application was submitted in accordance with the Article 13(1) of the Directive 2001/82/EC(i.e. an application for a generic product).
The competent authority to which the aid application was submitted shall be informed within seven days after the replacement.
An application was submitted under the decentralised procedure for Paclitaxel Hetero, 6 mg/mL, concentrate for solution for infusion on 15 May 2014.
In accordance with Article 7 of Regulation(EC) No 1831/2003, an application was submitted for the authorisation of a preparation of Bacillus subtilis DSM 29784.
The application was submitted as a generic of the reference product, Synulox Lactating Cow Intramammary Suspension marketed by Pfizer Ltd.
In accordance with Article 7 of Regulation(EC) No 1831/2003, an application was submitted for the authorisation of copper bilysinate.
The application was submitted to the reference Member State Denmark and to the concerned Member States(CMS) Germany, Ireland, Italy and the United Kingdom.
In exceptional circumstances, the retroactive effect of an authorisation may be extended further, butnot more than one year before the date the application was submitted, provided a proven economic need exists and.
Accordingly, the variation application was submitted to update the finished product specification by including the peptidoglycan test.
By way of derogation from Article 130(2) of Regulation(EU, Euratom) No 966/2012 and in duly justified cases, the Commission may, in the annual work programme for 2014, consider the costs directly linked to the implementation of supported actions to be eligible for financing from 1 January 2014, even if they were incurred by the beneficiary before the grant application was submitted.
A type II grouping of variations application was submitted under the mutual recognition procedure for Cardioxane 500 mg powder for solution for infusion.
By way of derogation from Article 130(2) of Regulation(EU, Euratom) No 966/2012, and in duly justified cases, the Commission may consider the costs directly linked to the implementation of the supported activities andincurred during the first six months of 2014 as eligible for financing from 1 January 2014, even if they were incurred by the beneficiary before the grant application was submitted.
The application was submitted to Italy which carried out the evaluation in agreement with France which had been designated rapporteur Member State by Regulation(EC) No 1490/2002.
In order to ensure continuity in the financial support provided under the Programme to the functioning of bodies, the Commission should be able, in the annual work programme for 2014, to consider the costs directly linked to the implementation of the supported activities to be eligible for financing, even ifthey were incurred by the beneficiary before the financing application was submitted.
The application was submitted for a mutual recognition procedure, using the legal basis of well-established use(Article 13a of Directive 2001/82/EC).
In an effort to compensate for those losses, an application was submitted in October 2009 to the European Globalisation Fund(EGF) on behalf of SR Technics workers.